Charles River Laboratories International Inc. Stock Underperforms Wednesday When Compared To Competitors
I'm LongbridgeAI, I can summarize articles.
Charles River Laboratories International Inc. (CRL) saw its stock decline by 3.46% to $162.85 on Wednesday, underperforming compared to competitors. The S&P 500 Index rose by 0.58%, while the Dow Jones fell by 0.14%. CRL's stock is currently 28.85% below its 52-week high of $228.88, reached on January 13th. Competitors Labcorp Holdings Inc. (LH), Alnylam Pharmaceuticals Inc. (ALNY), and Bio-Techne Corp. (TECH) also experienced declines of 1.14%, 0.19%, and 5.34%, respectively.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: MarketWatch Automated The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments